AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19377796 — intervention group
Group type: EXPERIMENTAL
Intervention: All trial groups (60%, 90%, 110% of AT)
Number of subjects: 48
Study 19377796 — intervention group
Group type: COMPARATOR
Intervention: Control group (without exercise)
Number of subjects: 48
Study 17936918 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.0 mg kg(‐1) + alfentanil 0.02 mg kg(‐1) + rocuronium 0.45 mg kg(‐1)
Number of subjects: 111
Study 17936918 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg(‐1) + alfentanil 0.02 mg kg(‐1) + rocuronium 0.45 mg kg(‐1)
Number of subjects: 111
Study 17936918 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3.0 mg kg(‐1) + alfentanil 0.02 mg kg(‐1) + rocuronium 0.45 mg kg(‐1)
Number of subjects: 111
Study 15235345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (IT-DEX)
Number of subjects: 39
Study 15235345 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 39
Study 11226989 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Doppler sonography (PDS) for strangulating obstruction
Number of subjects: 117
Study 11226989 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Doppler sonography (PDS) for simple obstruction
Number of subjects: 117
Study 9560861 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care (enhanced management of pharmacotherapy and brief psychoeducational interventions)
Number of subjects: 370
Study 9560861 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative Care (brief cognitive-behavioral therapy and enhanced patient education)
Number of subjects: 370
Study 9560861 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 370
Study 8175505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (0.5 mg/kg)
Number of subjects: 9
Study 8175505 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (5 mg/kg)
Number of subjects: 9
Study 6493047 — intervention group
Group type: EXPERIMENTAL
Intervention: Stediril-d 150/30 (150 micrograms levo-norgestrel and 30 micrograms ethinylestradiol)
Number of subjects: 50
Study 6493047 — intervention group
Group type: EXPERIMENTAL
Intervention: Ministat (750 micrograms lynestrenol and 37.5 micrograms ethinylestradiol)
Number of subjects: 50
Study 6493047 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study 30474147 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIE)
Number of subjects: 36
Study 30474147 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint Interval Exercise (SIE)
Number of subjects: 36
Study 30474147 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated-Sprint Exercise (RSE)
Number of subjects: 36
Study 30474147 — intervention group
Group type: EXPERIMENTAL
Intervention: All forms of acute interval exercise
Number of subjects: 36
Study 29496472 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg once per day
Number of subjects: 9795
Study 29496472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9795
Study 27631563 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual enhancement program with weekly follow‐ups
Number of subjects: 104
Study 27631563 — intervention group
Group type: COMPARATOR
Intervention: General educational material on postmenopause
Number of subjects: 104
Study 25456807 — intervention group
Group type: EXPERIMENTAL
Intervention: School food exposure (adolescents surveyed while school was in session)
Number of subjects: 1542
Study 25456807 — intervention group
Group type: COMPARATOR
Intervention: No school food exposure (adolescents surveyed when school was not in session)
Number of subjects: 1542
Study 23071510 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific music exposure during sleeping hours
Number of subjects: 0
Study 23071510 — intervention group
Group type: COMPARATOR
Intervention: No music exposure (Control group)
Number of subjects: 0
Study 20171409 — intervention group
Group type: EXPERIMENTAL
Intervention: Active patch containing 10% methyl salicylate and 3% l-menthol
Number of subjects: 208
Study 20171409 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 208
Study 20171409 — intervention group
Group type: EXPERIMENTAL
Intervention: Active patch
Number of subjects: 208
Study 17384176 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose deflazacort (DFZ) 7.5 mg for 6 months, followed by methyl prednisolone (MP) 4 mg for 6 months.
Number of subjects: 21
Study 17384176 — intervention group
Group type: COMPARATOR
Intervention: Methyl prednisolone (MP) 4 mg for 6 months, followed by low-dose deflazacort (DFZ) 7.5 mg for 6 months.
Number of subjects: 21
Study 17384176 — intervention group
Group type: COMPARATOR
Intervention: Group II vs Group I at 3 months showed a reduction of OPG (24% vs 6%, P = n.s.).
Number of subjects: 21
Study 17384176 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups from the sixth month.
Number of subjects: 21
Study 17310221 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone treatment for 8 weeks
Number of subjects: 10
Study 17310221 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (obese normoglycemic patients, n=10)
Number of subjects: 10
Study 14971531 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol SR 100 mg
Number of subjects: 50
Study 14971531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11145094 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab
Number of subjects: 4
Study 11145094 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 4
Study 11145094 — intervention group
Group type: COMPARATOR
Intervention: Immunosuppressive regimen (cyclosporin and prednisone) with daclizumab or basiliximab
Number of subjects: 4
Study 8799661 — intervention group
Group type: EXPERIMENTAL
Intervention: Semmes-Weinstein monofilaments
Number of subjects: 1001
Study 8799661 — intervention group
Group type: COMPARATOR
Intervention: Biothesiometer
Number of subjects: 1001
Study 8799661 — intervention group
Group type: COMPARATOR
Intervention: Palpation of pedal pulses
Number of subjects: 1001
Study 1634645 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 5
Study 1634645 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (200 mg)
Number of subjects: 5
Study 1634645 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (50 mg)
Number of subjects: 5
Study 1634645 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg)
Number of subjects: 5
Study 1634645 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol and Chlorthalidone combination (100 mg and 50 mg)
Number of subjects: 5
Study 1634645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 6695009 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic conditioning
Number of subjects: 45
Study 6695009 — intervention group
Group type: COMPARATOR
Intervention: Dietary educational sessions
Number of subjects: 45
Study 31204832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy modified for stalking offenders (DBT-S)
Number of subjects: 109
Study 31204832 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral anger management intervention
Number of subjects: 109
Study 31204832 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (DBT-S and anger management)
Number of subjects: 109
Study 27861708 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin D3 100,000 IU monthly
Number of subjects: 107
Study 27861708 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose vitamin D (placebo or 12,000 IU)
Number of subjects: 107
Study 26463527 — intervention group
Group type: EXPERIMENTAL
Intervention: Infracostal access approach
Number of subjects: 83
Study 26463527 — intervention group
Group type: COMPARATOR
Intervention: Supracostal access approach
Number of subjects: 83
Study 23421576 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 194
Study 23421576 — intervention group
Group type: COMPARATOR
Intervention: Counseling‐As‐Usual (CAU)
Number of subjects: 194
Study 21893379 — intervention group
Group type: EXPERIMENTAL
Intervention: Local mild hypothermia with IV rtPA (Group A)
Number of subjects: 0
Study 21893379 — intervention group
Group type: EXPERIMENTAL
Intervention: IV rtPA (Group B)
Number of subjects: 0
Study 21893379 — intervention group
Group type: COMPARATOR
Intervention: Conventional anti‐platelet aggregation (Group C)
Number of subjects: 0
Study 21893379 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 5 mg
Number of subjects: 12
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 10 mg
Number of subjects: 12
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose rosuvastatin 20 mg
Number of subjects: 12
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 5 mg
Number of subjects: 12
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 10 mg
Number of subjects: 12
Study 20166442 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-dose rosuvastatin 20 mg
Number of subjects: 12
Study 17084264 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months exercise program (1 hour, 3 times/week)
Number of subjects: 67
Study 15598476 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin + Fenofibrate combination therapy
Number of subjects: 48
Study 15598476 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin monotherapy
Number of subjects: 48
Study 11759142 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with interscalene block
Number of subjects: 52
Study 11759142 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 52
Study 9223543 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine (50, 100 or 200 microg)
Number of subjects: 40
Study 9223543 — intervention group
Group type: COMPARATOR
Intervention: Intravenous alfentanil
Number of subjects: 40
Study 9223543 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal neostigmine + Intravenous alfentanil
Number of subjects: 40
Study 7516376 — intervention group
Group type: COMPARATOR
Intervention: Terazosin, dosage not specified, administered once daily.
Number of subjects: 0
Study 7516376 — intervention group
Group type: COMPARATOR
Intervention: Terazosin, long-term treatment for more than two years.
Number of subjects: 0
Study 3953352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lorcainide (2 mg/kg bolus at 2 mg/min followed by 0.14 mg/min or 200 mg/24 hours)
Number of subjects: 28
Study 3953352 — intervention group
Group type: COMPARATOR
Intervention: Oral lorcainide (100 mg orally every 8 hours)
Number of subjects: 28
Study 30182192 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT) using the first-generation BAT device
Number of subjects: 0
Study 30182192 — intervention group
Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy (BAT) using the Barostim Neo system
Number of subjects: 0
Study 30182192 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 26381036 — intervention group
Group type: COMPARATOR
Intervention: Intra-abdominal lavage with normal saline (Group 1)
Number of subjects: 104
Study 26381036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-abdominal lavage with gentamicin-clindamycin solution (Group 2)
Number of subjects: 104
Study 25749596 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 0
Study 25749596 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 0
Study 25749596 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 0
Study 23378454 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (25,000 IU/d retinyl palmitate)
Number of subjects: 84
Study 23378454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 19769631 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Methoxypsoralen plus UVA (PUVA)
Number of subjects: 40
Study 19769631 — intervention group
Group type: COMPARATOR
Intervention: Medium-dose UVA1
Number of subjects: 40
Study 18729836 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with sequential addition of drugs (noliprel, noliprel-forte, metoprolol, amlodipine) for 12-14 months
Number of subjects: 99
Study 18729836 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy in patients with pronounced LVH (MMI 140 g/m2)
Number of subjects: 99
Study 18729836 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy in patients with minor initial diastolic dysfunction
Number of subjects: 99
Study 15922556 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (3 times per week for 15 weeks)
Number of subjects: 53
Study 15922556 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 53
Study 15922556 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 53
Study 15922556 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 53
Study 11823075 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional stenting (using NIR stents)
Number of subjects: 437
Study 11823075 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty alone (control group)
Number of subjects: 437
Study 9656312 — intervention group
Group type: EXPERIMENTAL
Intervention: Physioacoustic treatment group
Number of subjects: 42
Study 9656312 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 42
Study 9656312 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study 7644047 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 59
Study 7644047 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 59
Study 7644047 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 59
Study 7644047 — intervention group
Group type: COMPARATOR
Intervention: Nondrug baselines
Number of subjects: 59
Study 2667779 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine 0.1 mg.kg‐1 IV as premedication and isoflurane by inhalation
Number of subjects: 90
Study 2667779 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo and isoflurane by inhalation
Number of subjects: 90
Study 2667779 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo and halothane by inhalation
Number of subjects: 90
Study 2667779 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 90
Study 1087108 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical therapy (coronary bypass surgery)
Number of subjects: 91
Study 1087108 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 91
Study 31756535 — intervention group
Group type: EXPERIMENTAL
Intervention: ATG prophylaxis
Number of subjects: 40
Study 29080265 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous cord blood (ACB) infusion (1‐5 × 10^7 total nucleated cells per kilogram)
Number of subjects: 63
Study 29080265 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 29080265 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous cord blood (ACB) infusion
Number of subjects: 63
Study 26044471 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheimpflug noncontact tonometry with daily disposable hydrogel contact lenses (Dailies-nelfilcon A)
Number of subjects: 88
Study 26044471 — intervention group
Group type: COMPARATOR
Intervention: Scheimpflug noncontact tonometry without hydrogel contact lenses
Number of subjects: 88
Study 26044471 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of IOP measurements with and without CLs
Number of subjects: 88
Study 24171680 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-coated cups
Number of subjects: 100
Study 24171680 — intervention group
Group type: COMPARATOR
Intervention: Porous-coated cups
Number of subjects: 100
Study 20082240 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB)
Number of subjects: 48
Study 20082240 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 48
Study 19114582 — intervention group
Group type: EXPERIMENTAL
Intervention: STEPS (Schizophrenia Treatment and Education Programs)
Number of subjects: 57
Study 19114582 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 57
Study 16460384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (dementia care management program)
Number of subjects: 232
Study 16460384 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 232
Study 15269000 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility methods requiring more gross motor control during the first assessment interval.
Number of subjects: 62
Study 15269000 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility methods requiring less gross motor control during the second assessment interval.
Number of subjects: 62
Study 11097131 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) infusion (mean dose 2.4 +/- 0.9 mg/h), n = 33
Number of subjects: 48
Study 11097131 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride), n = 15
Number of subjects: 48
Study 9039716 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol
Number of subjects: 23
Study 9039716 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micrograms salbutamol
Number of subjects: 23
Study 9039716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 1314632 — intervention group
Group type: COMPARATOR
Intervention: CDE (cyclophosphamide/doxorubicin/etoposide)
Number of subjects: 178
Study 1314632 — intervention group
Group type: EXPERIMENTAL
Intervention: IMP (carboplatin 400 mg/m2 + ifosfamide 5 g/m2)
Number of subjects: 178
Study 1314632 — intervention group
Group type: EXPERIMENTAL
Intervention: VP (vincristine twice 2 mg)
Number of subjects: 178
Study 3850859 — intervention group
Group type: EXPERIMENTAL
Intervention: Transparent polyurethane (TP) dressings
Number of subjects: 737
Study 3850859 — intervention group
Group type: COMPARATOR
Intervention: Dry gauze (DG) dressings
Number of subjects: 737
Study 30183764 — intervention group
Group type: EXPERIMENTAL
Intervention: Children in school
Number of subjects: 534
Study 30183764 — intervention group
Group type: COMPARATOR
Intervention: Children not in school
Number of subjects: 534
Study 29137655 — intervention group
Group type: EXPERIMENTAL
Intervention: CT + Memory Support
Number of subjects: 178
Study 29137655 — intervention group
Group type: COMPARATOR
Intervention: CT-as-usual
Number of subjects: 178
Study 26671958 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebola vaccine efficacy trial starting after 1 August
Number of subjects: 100000
Study 26671958 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual recruitment in the trial
Number of subjects: 100000
Study 26671958 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusion of early cases in either arm of the trial
Number of subjects: 100000
Study 22505056 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 14
Study 22505056 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 14
Study 21940973 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraventricular recombinant tissue-type plasminogen activator
Number of subjects: 0
Study 18470741 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic attack-PTSD model
Number of subjects: 114
Study 18470741 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy
Number of subjects: 114
Study 17157120 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin 70/30
Number of subjects: 23
Study 17157120 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro 75/25
Number of subjects: 23
Study 17157120 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro 50/50
Number of subjects: 23
Study 17157120 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (no treatment)
Number of subjects: 23
Study 14624083 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention (frequent active cervical rotation, assessment and treatment according to McKenzie's principles)
Number of subjects: 97
Study 14624083 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention (early initiation within 96 hours)
Number of subjects: 97
Study 14624083 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention (initial rest, soft collar, gradual self-mobilization)
Number of subjects: 97
Study 14624083 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed active intervention (initiated 14 days post-collision)
Number of subjects: 97
Study 10844834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium infusion
Number of subjects: 17
Study 10844834 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium infusion
Number of subjects: 17
Study 8852235 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupation based health and fitness program
Number of subjects: 1504
Study 8852235 — intervention group
Group type: COMPARATOR
Intervention: Usual training (Control)
Number of subjects: 1504
Study 1320920 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (median duration of 60 months)
Number of subjects: 747
Study 6730581 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic basic diet enriched by polyene fatty acids
Number of subjects: 77
Study 6730581 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic basic diet rich in polyene fatty acids
Number of subjects: 77
Study 2870315 — intervention group
Group type: EXPERIMENTAL
Intervention: Local tetrachlorodecaoxygen anion complex (TCDO)
Number of subjects: 271
Study 2870315 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 271
Study 29378515 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (FBT)
Number of subjects: 3
Study 29378515 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min brisk walk followed by computerized cognitive training (Ex-FBT)
Number of subjects: 3